SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-194844
Filing Date
2014-05-12
Accepted
2014-05-12 16:15:00
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d690225d10q.htm 10-Q 524988
2 EX-10.1 d690225dex101.htm EX-10.1 61817
3 EX-31.1 d690225dex311.htm EX-31.1 8095
4 EX-31.2 d690225dex312.htm EX-31.2 8135
5 EX-32.1 d690225dex321.htm EX-32.1 4585
  Complete submission text file 0001193125-14-194844.txt   3682703

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arna-20140331.xml EX-101.INS 418863
7 XBRL TAXONOMY EXTENSION SCHEMA arna-20140331.xsd EX-101.SCH 41903
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20140331_cal.xml EX-101.CAL 46714
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20140331_def.xml EX-101.DEF 231032
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20140331_lab.xml EX-101.LAB 329470
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20140331_pre.xml EX-101.PRE 272568
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 14833589
SIC: 2834 Pharmaceutical Preparations